According to the Finnish National Innovation Grants Agency, the blood biomarker technology developed by Finland's Brainshake Company can expand the biological data obtained by routine blood tests by 50 times, which will have a positive impact on the prevention of chronic diseases.
Metabolic blood biomarkers are key tools for understanding chronic diseases such as cardiovascular disease and diabetes. The current risk of these diseases is diagnosed by five blood biomarkers obtained by routine testing, such as cholesterol levels used to estimate heart disease risk.
Extensive biomarker data can help raise human awareness of disease and risk prediction to a new level, yet access to large amounts of biomarker data is subject to high cost constraints that require multiple tests on different biomarker groups. Because current clinical biochemical laboratories are usually optimized only for measuring a single biomarker.
Brainshake's biomarker analysis platform can provide more than 220 biomarkers from a single blood sample, 50 times more than the usual laboratory method, at a cost comparable to conventional blood tests that provide only five biomarkers. This is a completely different method of blood testing. Researchers do not directly observe the chemical processes in blood samples, but directly analyze their molecular composition.
Dried Chive, Chive Rings, Dehydrated Chives, Dehydrated Chive Rings, Dried Chive Flakes
Jiangsu Tiankang Food Co., Ltd. , https://www.tiankangfood.com